Bispecific soluble cytokine receptor-nanobody fusions inhibit Interleukin (IL-)6 trans-signaling and IL-12/23 or tumor necrosis factor (TNF) signaling.
In: Journal of Biological Chemistry, Jg. 299 (2023-11-01), Heft 11, S. 1-13
academicJournal
Zugriff:
Titel: |
Bispecific soluble cytokine receptor-nanobody fusions inhibit Interleukin (IL-)6 trans-signaling and IL-12/23 or tumor necrosis factor (TNF) signaling.
|
---|---|
Autor/in / Beteiligte Person: | Gesiorowski, Annika ; Ettich, Julia ; Werner, Julia ; Wittich, Christoph ; Pieper, Stephan ; Padrini, Giacomo ; Behnke, Kristina ; Floss, Doreen M. ; Lang, Philipp A. ; Moll, Jens M. ; Scheller, Jürgen |
Zeitschrift: | Journal of Biological Chemistry, Jg. 299 (2023-11-01), Heft 11, S. 1-13 |
Veröffentlichung: | 2023 |
Medientyp: | academicJournal |
ISSN: | 0021-9258 (print) |
DOI: | 10.1016/j.jbc.2023.105343 |
Sonstiges: |
|